VFY VITRAFY FPO [VFY]
Technology · Software - Infrastructure
· website
$3.70
52wk 1.16 – 3.91
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About VITRAFY FPO [VFY]
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia. The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices. It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand. The company's cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs. Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$282.09M
P/E (trailing)
26.43
P/E (forward)
-17.42
EPS (trailing)
0.14
Dividend yield
—
Payout ratio
0.0%
Beta
—
EV / EBITDA
-12.42
Price / Book
10.91
ROE
-50.2%
Operating margin
-378.6%
Net margin
0.0%
Total cash
$22.80M
Total debt
$348,464
Current ratio
13.47
Debt / Equity
0.02
Free cash flow
$-7.51M
Avg volume
65,649
Latest annual results
(FY ending 30 Jun 2025)
- Revenue$65.11K
- Gross profit$65.11K
- Operating income-$16.57M
- Net income-$32.71M
- Diluted EPS-0.73
- Free cash flow-$8.80M
- Net debt-$19.13M